Publisher： Future Medicine
ISSN： 1741-0541
Source： Personalized Medicine, Vol.2, Iss.2, 2005-05, pp. : 89-92
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New Combinations with Herceptin® in Metastatic Breast Cancer
Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. :
Access to resources
Recommend
First-Line Herceptin® Monotherapy in Metastatic Breast Cancer
Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. :
Taxane therapy for early stage breast cancer
By Nabholtz Jean-Marc Gligorov Joseph
Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. :
Retrospective Analysis of the Safety of Herceptin® Immunotherapy in Metastatic Breast Cancer
Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. :